Published in Drug Dev Ind Pharm on December 08, 2014
Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm (2007) 2.07
Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants. Drug Dev Ind Pharm (2007) 1.94
Recent advances in neonatal pharmacotherapy. Ann Pharmacother (2006) 1.38
Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films. J Pharm Sci (2005) 1.16
Melt extrusion with poorly soluble drugs. Int J Pharm (2012) 1.15
Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea. Int J Pharm (2007) 1.09
Self-assembling peptide amphiphile-based nanofiber gel for bioresponsive cisplatin delivery. Mol Pharm (2009) 1.07
Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents. Bioorg Med Chem (2006) 0.98
Iontophoretic permselective property of human nail. J Dermatol Sci (2007) 0.97
Noninvasive transcutaneous sampling of glucose by electroporation. J Diabetes Sci Technol (2008) 0.95
Sorocenols G and H, anti-MRSA oxygen heterocyclic Diels-Alder-type adducts from Sorocea muriculata roots. J Nat Prod (2008) 0.94
Methicillin-resistant Staphylococcus aureus (MRSA)-active metabolites from Platanus occidentalis (American Sycamore). J Nat Prod (2009) 0.94
Stabilization of hot-melt extrusion formulations containing solid solutions using polymer blends. AAPS PharmSciTech (2007) 0.92
Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: delineation of passive diffusion versus transporter involvement. Pharm Res (2008) 0.92
Trans-ungual iontophoretic delivery of terbinafine. J Pharm Sci (2009) 0.91
Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF. AAPS PharmSciTech (2015) 0.91
Preformulation studies of a prodrug of Delta9-tetrahydrocannabinol. AAPS PharmSciTech (2008) 0.91
Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech (2010) 0.90
Ungual and transungual drug delivery. Drug Dev Ind Pharm (2011) 0.89
Water vapor sorption of hot-melt extruded hydroxypropyl cellulose films: effect on physico-mechanical properties, release characteristics, and stability. J Pharm Sci (2004) 0.89
Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology. AAPS PharmSciTech (2012) 0.88
Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion. Drug Dev Ind Pharm (2012) 0.88
The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films. Eur J Pharm Sci (2004) 0.87
The use of near-infrared spectroscopy for the quantitation of a drug in hot-melt extruded films. Drug Dev Ind Pharm (2004) 0.86
Chemical stabilization of a Delta9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: role of microenvironment pH. AAPS PharmSciTech (2006) 0.86
Antifungal activity of artemisinin derivatives. J Nat Prod (2005) 0.86
Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia. J Control Release (2009) 0.86
Transcutaneous sampling of ciprofloxacin and 8-methoxypsoralen by electroporation (ETS technique). Int J Pharm (2008) 0.85
Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis. J Pharm Sci (2009) 0.85
Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation. J Ocul Pharmacol Ther (2013) 0.85
mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer. Expert Opin Drug Deliv (2014) 0.84
Oral transmucosal delivery of domperidone from immediate release films produced via hot-melt extrusion technology. Pharm Dev Technol (2012) 0.84
Upregulation of endogenous neurotrophin levels in the brain by intranasal administration of carnosic acid. J Pharm Sci (2011) 0.84
Heat-induced superaggregation of amphotericin B attenuates its ability to induce cytokine and chemokine production in the human monocytic cell line THP-1. J Antimicrob Chemother (2003) 0.84
Polymeric systems for amorphous Delta 9-tetrahydrocannabinol produced by a hot-melt method. Part I: chemical and thermal stability during processing. J Pharm Sci (2006) 0.84
Chemical stability and bioadhesive properties of an ester prodrug of Delta 9-tetrahydrocannabinol in poly(ethylene oxide) matrices: effect of formulation additives. Int J Pharm (2008) 0.83
Transdermal drug delivery enhanced by low voltage electropulsation (LVE). Pharm Dev Technol (2009) 0.83
Characterization of hot-melt extruded drug delivery systems for onychomycosis. Eur J Pharm Biopharm (2006) 0.83
Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation. Int J Pharm (2009) 0.83
Electroporation: an avenue for transdermal drug delivery. Curr Drug Deliv (2010) 0.83
In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil. J Pharm Pharmacol (2008) 0.83
Synthesis and biological evaluation of tricyclic guanidine analogues of batzelladine K for antimalarial, antileishmanial, antibacterial, antifungal, and anti-HIV activities. Chem Biol Drug Des (2013) 0.82
Continuous production of fenofibrate solid lipid nanoparticles by hot-melt extrusion technology: a systematic study based on a quality by design approach. AAPS J (2014) 0.82
S-Euglobals: biomimetic synthesis, antileishmanial, antimalarial, and antimicrobial activities. Bioorg Med Chem (2007) 0.82
Constant voltage 'Iron'tophoresis. Pharm Dev Technol (2010) 0.82
"ChilDrive": a technique of combining regional cutaneous hypothermia with iontophoresis for the delivery of drugs to synovial fluid. Pharm Res (2009) 0.81
Influence of processing parameters and formulation factors on the bioadhesive, temperature stability and drug release properties of hot-melt extruded films containing miconazole. AAPS PharmSciTech (2014) 0.81
2-N-Methyl modifications and SAR studies of manzamine A. Bioorg Med Chem (2008) 0.81
Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake. J Pharm Sci (2009) 0.81
The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets. J Pharm Sci (2014) 0.80
Influence of plasticizers on the stability and release of a prodrug of Delta(9)-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices. Eur J Pharm Biopharm (2008) 0.80
Transungual delivery of terbinafine by iontophoresis in onychomycotic nails. Drug Dev Ind Pharm (2011) 0.80
Iontophoresis across the proximal nail fold to target drugs to the nail matrix. J Pharm Sci (2012) 0.80
Novel pH-sensitive polyacetal-based block copolymers for controlled drug delivery. Int J Pharm (2010) 0.80
Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins. AAPS PharmSciTech (2011) 0.80
Evaluation of the recrystallization kinetics of hot-melt extruded polymeric solid dispersions using an improved Avrami equation. Drug Dev Ind Pharm (2015) 0.79
Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery. AAPS PharmSciTech (2012) 0.79
Antiprotozoal and antimicrobial compounds from the plant pathogen Septoria pistaciarum. J Nat Prod (2012) 0.79
Microporation and 'iron'tophoresis for treating iron deficiency anemia. Pharm Res (2012) 0.79
Polymeric systems for amorphous Delta9-tetrahydrocannabinol produced by a hot-melt method. Part II: Effect of oxidation mechanisms and chemical interactions on stability. J Pharm Sci (2006) 0.79
Bioactive 1,4-dihydroxy-5-phenyl-2-pyridinone alkaloids from Septoria pistaciarum. J Nat Prod (2010) 0.79
Delivery of brain-derived neurotrophic factor via nose-to-brain pathway. Pharm Res (2011) 0.79
Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy. J Pharm Sci (2011) 0.79
Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery. Acta Biomater (2011) 0.79
Formulation and evaluation of carnosic acid nanoparticulate system for upregulation of neurotrophins in the brain upon intranasal administration. J Drug Target (2012) 0.79
Electroporation and transcutaneous sampling (ETS) of acyclovir. J Dermatol Sci (2007) 0.79
New secondary metabolites from bioactive extracts of the fungus Armillaria tabescens. Nat Prod Res (2012) 0.78
A platform for predicting and enhancing model drug delivery across the human nail plate. Drug Dev Ind Pharm (2010) 0.78
Magnetophoresis in combination with chemical enhancers for transdermal drug delivery. Drug Dev Ind Pharm (2011) 0.78
Formulation optimization of hot-melt extruded abuse deterrent pellet dosage form utilizing design of experiments. J Pharm Pharmacol (2013) 0.78
Ocular disposition of the hemiglutarate ester prodrug of ∆⁹-Tetrahydrocannabinol from various ophthalmic formulations. Pharm Res (2013) 0.77
Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins. AAPS PharmSciTech (2010) 0.77
Role of cyclodextrin complexation in felodipine-sustained release matrix tablets intended for oral transmucosal delivery: in vitro and ex vivo characterization. Pharm Dev Technol (2011) 0.77
Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan. J Microbiol Immunol Infect (2011) 0.77
Development and evaluation of a pH-dependent sustained release tablet for irritable bowel syndrome. Drug Dev Ind Pharm (2009) 0.77
Delivery of cefotaxime to the brain via intranasal administration. Drug Dev Ind Pharm (2011) 0.77
Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique. J Pharm Sci (2009) 0.77
Off-line and on-line measurements of drug-loaded hot-melt extruded films using Raman spectroscopy. Int J Pharm (2008) 0.77
Investigation of phase diagrams and physical stability of drug-polymer solid dispersions. Pharm Dev Technol (2014) 0.77
Iontophoretic drug delivery for the treatment of scars. J Pharm Sci (2014) 0.77
Effect of polyethylene glycols on the trans-ungual delivery of terbinafine. Curr Drug Deliv (2010) 0.77
Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy. Expert Opin Drug Deliv (2014) 0.77
An ex vivo toe model used to assess applicators for the iontophoretic ungual delivery of terbinafine. Pharm Res (2009) 0.77
A quality by design approach to understand formulation and process variability in pharmaceutical melt extrusion processes. J Pharm Pharmacol (2015) 0.76
Influence of process and formulation parameters on dissolution and stability characteristics of Kollidon® VA 64 hot-melt extrudates. AAPS PharmSciTech (2014) 0.76
Bilayered nail lacquer of terbinafine hydrochloride for treatment of onychomycosis. J Pharm Sci (2010) 0.76
Enhancement of nose-brain delivery of therapeutic agents for treating neurodegenerative diseases using peppermint oil. Pharmazie (2010) 0.76
Delivery of itraconazole from extruded HPC films. Drug Dev Ind Pharm (2007) 0.76
In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride. Pharm Dev Technol (2010) 0.75
Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology. Expert Opin Drug Deliv (2014) 0.75
Transdermal iontophoretic delivery of propofol: a general anaesthetic in the form of its phosphate salt. J Pharm Sci (2012) 0.75
In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets. Eur J Pharm Biopharm (2007) 0.75
Minimally invasive transdermal delivery of iron-dextran. J Pharm Sci (2012) 0.75
Controlled-release injectable containing terbinafine/PLGA microspheres for onychomycosis treatment. J Pharm Sci (2014) 0.75